Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …

BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …

Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …

Importance Passive antibody transfer is a longstanding treatment strategy for infectious
diseases that involve the respiratory system. In this context, human convalescent plasma has …

The mRNA vaccines BNT162b2 and mRNA-1273 have robust safety and efficacy against
COVID-19 among immunocompetent individuals (Creech et al., 2021). However, many …

Importance COVID-19 is a life-threatening illness for many patients. Prior studies have
established hematologic cancers as a risk factor associated with particularly poor outcomes from …

Importance Patients who are immunocompromised have increased risk for morbidity and
mortality associated with coronavirus disease 2019 (COVID-19) because they less frequently …

To determine the effect of COVID-19 convalescent plasma on mortality, we aggregated
patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose-…

Although over 100 studies and reviews have examined the ergogenic effects of dietary nitrate
(NO 3−) supplementation in young, healthy men and women, it is unclear if participant and …

It has been reported that 15%–25% of patients with hematologic malignancies fail to make
anti-spike (anti-S) antibodies in response to full dosing of SARS-CoV-2 mRNA vaccines (…